About SCA12

Symptoms, progression and life expectancy

Symptoms usually develop gradually, and both their timing and their severity differ between people — and the condition itself tends to move slowly.

Symptoms and everyday impact

Reported features include:

  • Tremor usually first

    A shakiness in the arms that shows up when you use them rather than at rest, sometimes in the head too. It was the first symptom for about three in four people in the largest Indian cohort, and because it looks like commoner tremors it often leads to a first, different diagnosis. Source

  • Balance and coordination

    Feeling unsteady, or veering to one side when walking.

  • Walking

    Difficulty walking, which may progress over time.

  • Speech

    Slurred or effortful speech — the medical word is dysarthria.

  • Mood, memory and thinking

    Reported more often than people expect: low mood, anxiety, irritability, and for some people difficulty with memory and concentration.

Every one of these can also occur in other conditions, some of them common and treatable. That is precisely why a qualified clinical team, rather than a symptom list, is what leads to an accurate answer.

See also: how SCA12 is identified and what helps with these symptoms.

Progression, and life expectancy

No published study has measured life expectancy in SCA12. We searched the literature for this page in September 2026 and there is no survival study of the condition. What exists is the experience of the clinicians who have followed patients, and it points one way:

  • The National Ataxia Foundation states that lifespan is generally not shortened by the disease.
  • The GeneReviews chapter on SCA12 — written by the clinicians who first described it, last updated in 2011 and since retired because the condition is so rare — says SCA12 “progresses slowly and may not have a major impact on longevity”, and notes that several members of the original American family remained employed throughout adulthood.

What progression usually looks like, from the largest published cohort (49 patients, NIMHANS Bengaluru, 2022):

  • Tremor comes first, more often in one arm than both, and spreads to both arms over time.
  • Balance and walking difficulties follow, usually years later. When first seen at the clinic, patients had had tremor for about seven years on average and unsteadiness for about five.
  • Cerebellar signs become more prominent over the years and can come to overshadow the tremor.
  • Most people were still walking unaided. Eight of the 49 needed a walking aid at their first visit, about six years into the illness; the other 41 were walking without one, on average nine years in.
  • The repeat count did not predict the age symptoms began in this cohort.

Two cautions. A hospital cohort describes the people who reached a specialist centre, so milder courses are under-represented. And the range is wide: onset spans decades even within one family, and the pace of change varies just as much, so a group average says little that is reliable about any one person. The person to ask is your own neurologist, who can see your history; “what should I expect over the next few years?” is worth asking directly.

Sources National Ataxia Foundation · GeneReviews SCA12 chapter (2011, retired 2018) · NIMHANS cohort, 2022